WinstonWınston
Phreesia logo

Phreesia

PHR
41
Medical - Healthcare Information Services · Healthcare
Winston Score
41
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Phreesia makes software that helps doctors' offices and hospitals manage patient check-ins. Instead of filling out paper forms in a waiting room, patients use Phreesia's digital tablets or mobile tools to enter their information, sign forms, and even pay their bills. The company sells its platform to healthcare providers across the United States, serving medical practices of all sizes.

Phreesia charges healthcare providers a recurring software fee, which gives it a subscription-style revenue base. It also earns money from payment processing when patients pay their medical bills through the platform, and from life sciences companies that use Phreesia's network to deliver health information to patients. The company operates almost entirely in the U.S. and has built a large installed base of provider clients, which makes switching to a competitor costly and time-consuming. Its main challenge is reaching consistent profitability, as it continues to spend heavily on sales and technology while operating margins remain near breakeven.

Winston Score History

Politician Trades

2 trades / 12mo

1 Congressional buy and 1 sell on PHR in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+15.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+119.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

19.8%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

$74M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Phreesia is a rare growth stock that's already generating positive cash flow while growing at 16%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
43.0%
Healthy — 43.0% gross margin
Operating Margin
2.9%
Thin — 2.9% operating margin
ROCE
0.8%
Weak — 0.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+13.0%
Fast-growing sales (13.0% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
13.8%
Converts sales into free cash efficiently (13.8%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.28
Conservative — low debt load (0.28)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
70.7x
no trend
Expensive — P/E 70.7

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+56.6
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (70.7 → 14.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial